Blood-based biomarkers used to evaluate dementia pathology include the amyloid-beta 42/40 ratio, phosphorylated tau 217, neurofilament light chain, and glial fibrillary acidic protein

Bb5a31f81Topic

Science

The systematic study of the natural world through observation, experiment, and theory.

1,948 claims·1 news story

0